Prevention of cervical cancer in women's hands: Mexico leads the way

The Lancet

Volumn 378, Issue 9806, 2011, Pages 1829-1831

  Muñoz, Nubia ^a   Herrero, Rolando ^b  

^a Colombian Cancer Institute ^*  (Colombia)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; VIRUS DNA;

AGE DISTRIBUTION; CANCER CONTROL; CANCER DIAGNOSIS; CANCER INVASION; CANCER PREVENTION; COLPOSCOPY; COMPARATIVE EFFECTIVENESS; DIAGNOSTIC VALUE; EMERGENCY HEALTH SERVICE; EVIDENCE BASED MEDICINE; FINLAND; GYNECOLOGICAL EXAMINATION; HEALTH CARE POLICY; HOME DIAGNOSTIC TEST; HUMAN; HUMAN PAPILLOMAVIRUS TEST; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEXICO; NOTE; PAPILLOMAVIRUS INFECTION; PATIENT REFERRAL; PRECANCER; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF EXAMINATION; SENSITIVITY ANALYSIS; SERODIAGNOSIS; SQUAMOUS CELL; UNITED STATES; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VACCINATION;

EID: 82255183100     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61101-X     Document Type: Note

References (12)

1. E Lazcano-Ponce, AT Lorincz, A Cruz-Valdez et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial Lancet 2011 10.1016/S0140-6736(11)61522-5 published online Nov 2.
2. J Ting, DT Kruzikas, JS Smith A global review of age-specific and overall prevalence of cervical lesions Int J Gynecol Cancer 20 2010 1244 1249
3. AP Sowjanya, P Paul, H Vedantham for the Community Acess to Cervical Health Study Group Suitability of self-collected vaginal samples for cervical cancer screening in peri-urban villages in Andhra Pradesh, India Cancer Epidemiol Biomarkers Prev 18 2009 1373 1378
4. JL Belinson, H Du, B Yang et al. Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing Int J Cancer 2011 10.1002/ijc.26202 published online May 31.
5. Y Qiao, JW Sellors, PS Eder et al. A new HPV-DNA test for cervical cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China Lancet Oncol 9 2008 929 936
6. M Leinonen, P Neiminen, L Kotaniemi-Talonen et al. Age-specific evaluation of primary human papillomavirus screening h conventional cytology in a randomized setting J Natl Cancer Inst 101 2009 1612 1623
7. A Balasubramanian, SL Kulasingam, A Baer et al. Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples J Low Genit Tract Dis 14 2010 185 195
8. WHO Globocan 2008: the Globocan project http://globocan.iarc.fr 2010 (accessed Oct 3, 2011).
9. M Schiffman, N Wentzensen, S Wacholder, W Kinney, JC Gage, PE Castle Human papillomavirus testing in the prevention of cervical cancer J Natl Cancer Inst 103 2011 368 383
10. J Cuzick, M Arbyn, R Sankaranarayanan et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries Vaccine 26 suppl 10 2008 K29 K41
11. R Herrero, C Ferreccio, J Salmerón et al. New approaches to cervical cancer screening in Latin America and the Caribbean Vaccine 26 suppl 11 2008 L49 L58
12. N Muñoz, EL Franco, R Herrero et al. Recommendations for cervical cancer prevention in Latin America and the Caribbean Vaccine 26 suppl 11 2008 L96 107